User profiles for John M. Davis
John M DavisUniversity of IL at Chicago Verified email at psych.uic.edu Cited by 96566 |
A meta-analysis of the efficacy of second-generation antipsychotics
JM Davis, N Chen, ID Glick - Archives of general psychiatry, 2003 - jamanetwork.com
Background Consensus panel recommendations regarding choice of an antipsychotic agent
for schizophrenia differ markedly, but most consider second-generation antipsychotics (…
for schizophrenia differ markedly, but most consider second-generation antipsychotics (…
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a …
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a …
A cholinergic-adrenergic hypothesis of mania and depression
DS Janowsky, JM Davis, MK El-Yousef, HJ Sekerke - The Lancet, 1972 - Elsevier
Central cholinergic factors may play a role in the ætiology of affective disorders. Specifically,
a given affective state may represent a balance between central cholinergic and adrenergic …
a given affective state may represent a balance between central cholinergic and adrenergic …
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Background Because of the debate about whether second-generation antipsychotic drugs
are better than first-generation antipsychotic drugs, we did a meta-analysis of randomised …
are better than first-generation antipsychotic drugs, we did a meta-analysis of randomised …
Physical health monitoring of patients with schizophrenia
…, RW Buchanan, DE Casey, JM Davis… - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Schizophrenia is associated with several chronic physical illnesses and a shorter
life expectancy, compared with life expectancy in the general population. One approach …
life expectancy, compared with life expectancy in the general population. One approach …
Efficacy of divalproex vs lithium and placebo in the treatment of mania
…, PG Janicak, F Petty, SC Dilsaver, JM Davis… - Jama, 1994 - jamanetwork.com
Objective. —To compare the effectiveness of divalproex sodium with that of lithium and placebo
in patients with acute mania. Design. —Randomized, double-blind, parallel-group study …
in patients with acute mania. Design. —Randomized, double-blind, parallel-group study …
Norepinephrine in depressive reactions: A review
WE Bunney, JM Davis - Archives of General Psychiatry, 1965 - jamanetwork.com
Introduction LITTLE IS known about the possible etiological biochemical factors relating to
depressive reactions. Clinical evidence suggests that many depressions respond to the …
depressive reactions. Clinical evidence suggests that many depressions respond to the …
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study
Background Reelin (RELN) is a glycoprotein secreted preferentially by cortical γ-aminobutyric
acid-ergic (GABAergic) interneurons (layers I and II) that binds to integrin receptors …
acid-ergic (GABAergic) interneurons (layers I and II) that binds to integrin receptors …
Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study
JR Hibbeln, JM Davis, C Steer, P Emmett, I Rogers… - The Lancet, 2007 - thelancet.com
Background Seafood is the predominant source of omega-3 fatty acids, which are essential
for optimum neural development. However, in the USA, women are advised to limit their …
for optimum neural development. However, in the USA, women are advised to limit their …
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Background Relapse prevention with antipsychotic drugs compared with placebo in patients
with schizophrenia has not been sufficiently addressed by previous systematic reviews. We …
with schizophrenia has not been sufficiently addressed by previous systematic reviews. We …